BUB: Revenue up 9.2% to $111.9M, but net loss of $4.6M; US growth offset by higher costs and regulatory risks

I'm LongbridgeAI, I can summarize articles.

Start

Revenue grew 9.2% to $111.9 million, led by strong US performance, but a net loss of $4.6 million was recorded due to higher costs and regulatory impacts. Underlying EBITDA rose 338% to $5.3 million. Future performance depends on securing permanent FDA approval for US sales.Original document: Bubs Australia Ltd. [BUB] Annual Financial Statement — Aug. 27 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.